Immucell (ICCC) Assets Average (2011 - 2026)

Immucell (ICCC) has reported Assets Average for 16 consecutive years, with $44.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 1.14% year-over-year to $44.6 million; the trailing twelve-month figure through Jun 2026 stood at $44.6 million (up 1.14% YoY), and the FY2025 full-year result was $43.8 million, down 1.43% from the prior year.
• Assets Average grew to $44.6 million in Q2 2026 per ICCC's latest filing, from $44.1 million in the prior quarter.
• Across five years, Assets Average topped out at $46.3 million in Q2 2022 and bottomed at $42.5 million in Q2 2024.
• Historically, Assets Average has averaged $44.5 million across 5 years, with a median of $44.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Assets Average climbed 14.0% in 2022, then retreated 5.99% in 2023.
• Over 5 years, Assets Average stood at $45.6 million in 2022, then declined by 3.19% to $44.2 million in 2023, then gained by 1.35% to $44.8 million in 2024, then retreated by 1.44% to $44.1 million in 2025, then climbed by 1.02% to $44.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $44.6 million, $44.1 million, and $44.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.